HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefan Rutkowski Selected Research

Medulloblastoma

3/2022Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial.
1/2022Local and Systemic Therapy of Recurrent Medulloblastomas in Children and Adolescents: Results of the P-HIT-REZ 2005 Study.
1/2022Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial.
12/2021SIOP PNET5 MB Trial: History and Concept of a Molecularly Stratified Clinical Trial of Risk-Adapted Therapies for Standard-Risk Medulloblastoma.
8/2021Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial.
1/2021Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.
11/2020Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma - A Report From the HIT 2000 Trial.
1/2020Effects of the growth pattern of medulloblastoma on short-term neurological impairments after surgery: results from the prospective multicenter HIT-SIOP PNET 4 study.
1/2020Germline GPR161 Mutations Predispose to Pediatric Medulloblastoma.
1/2020Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stefan Rutkowski Research Topics

Disease

63Neoplasms (Cancer)
10/2022 - 05/2004
59Medulloblastoma
03/2022 - 03/2005
19Primitive Neuroectodermal Tumors (PNET)
11/2020 - 04/2006
14Ependymoma
01/2022 - 12/2005
8Residual Neoplasm
12/2021 - 08/2006
8Brain Neoplasms (Brain Tumor)
01/2020 - 03/2005
8Neoplasm Metastasis (Metastasis)
01/2020 - 03/2005
7Glioma (Gliomas)
09/2019 - 05/2004
4Pinealoma (Pineoblastoma)
01/2020 - 09/2012
3Glioblastoma (Glioblastoma Multiforme)
01/2022 - 09/2006
3Disease Progression
10/2017 - 08/2011
2Hearing Loss (Hearing Impairment)
10/2021 - 09/2012
2Pathologic Complete Response
01/2021 - 05/2011
2Carcinogenesis
01/2020 - 06/2014
2Sarcoma (Soft Tissue Sarcoma)
01/2018 - 02/2013
2Diffuse Intrinsic Pontine Glioma
05/2011 - 02/2010
1Brain Stem Neoplasms (Brain Stem Tumor)
01/2022
1Pleomorphic Adenoma
11/2021
1Tinnitus
10/2021
1Supratentorial Neoplasms
11/2020
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2020
1Clostridium Infections
01/2019
1Chromosome Aberrations (Chromosome Abnormalities)
12/2018
1Craniopharyngioma (Craniopharyngiomas)
10/2017
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016
1Seizures (Absence Seizure)
11/2015
1Olivary Degeneration
05/2014
1Neuroectodermal Tumors (Neuroectodermal Tumor)
08/2013
1Astrocytoma (Pilocytic Astrocytoma)
08/2013
1Peripheral Nervous System Diseases (PNS Diseases)
03/2013

Drug/Important Bio-Agent (IBA)

15Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2006
14Biological ProductsIBA
01/2021 - 05/2007
9DNA (Deoxyribonucleic Acid)IBA
11/2015 - 05/2007
7Messenger RNA (mRNA)IBA
09/2017 - 05/2007
5Proteins (Proteins, Gene)FDA Link
01/2020 - 05/2011
4Pharmaceutical PreparationsIBA
12/2021 - 12/2008
4ParaffinIBA
11/2015 - 05/2007
4Formaldehyde (Formol)FDA Link
11/2015 - 05/2007
3RNA (Ribonucleic Acid)IBA
10/2022 - 08/2012
3MicroRNAs (MicroRNA)IBA
01/2021 - 06/2014
3Methotrexate (Mexate)FDA LinkGeneric
01/2020 - 05/2011
2Etoposide (VP 16)FDA LinkGeneric
01/2022 - 01/2016
2Valproic Acid (Depakote)FDA LinkGeneric
01/2022 - 12/2008
2Temozolomide (Temodar)FDA LinkGeneric
01/2021 - 05/2011
2CytokinesIBA
01/2018 - 05/2011
2Radiation-Sensitizing AgentsIBA
12/2014 - 09/2011
2Lomustine (CCNU)FDA Link
07/2014 - 05/2011
2Vincristine (Oncovin)FDA LinkGeneric
07/2014 - 09/2011
2ElementsIBA
12/2008 - 09/2006
1Vinblastine (Vinblastine Sulfate)FDA Link
01/2022
1Carboplatin (JM8)FDA LinkGeneric
01/2022
1PlatinumIBA
10/2021
1Arsenic Trioxide (Trisenox)FDA Link
01/2021
1NucleotidesIBA
01/2020
1ProteomeIBA
01/2020
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2020
1Mitogen-Activated Protein KinasesIBA
01/2018
1Interferon-alpha (Interferon Alfa)IBA
10/2017
1TropomyosinIBA
09/2017
1Phosphotransferases (Kinase)IBA
09/2017
1TenascinIBA
01/2017
1CateninsIBA
02/2015
1LithiumIBA
12/2014
1Cisplatin (Platino)FDA LinkGeneric
07/2014
1ChromatinIBA
06/2014
1GadoliniumIBA
05/2014
1Telomerase (Telomerase Reverse Transcriptase)IBA
12/2013
1Somatostatin Receptors (Somatostatin Receptor)IBA
08/2013
1IntegrinsIBA
05/2012
1CaspasesIBA
11/2011
1siomycin AIBA
11/2011
1ThiazolesIBA
11/2011
1Anti-Bacterial Agents (Antibiotics)IBA
11/2011
1FollistatinIBA
10/2011
1epothilone B (EPO906)IBA
09/2011
1taxaneIBA
09/2011
1Excipients (Suspending Agents)IBA
09/2011
1O(6)-Methylguanine-DNA MethyltransferaseIBA
05/2011
1MethyltransferasesIBA
05/2011
11,4-dinitro-2-methyl-2-buteneIBA
11/2010

Therapy/Procedure

37Radiotherapy
03/2022 - 05/2004
37Drug Therapy (Chemotherapy)
01/2022 - 03/2005
26Therapeutics
01/2022 - 05/2004
8Craniospinal Irradiation
08/2021 - 08/2006
7Maintenance Chemotherapy
12/2021 - 05/2009
5Aftercare (After-Treatment)
01/2022 - 07/2011
4Chemoradiotherapy
01/2018 - 04/2011
4Induction Chemotherapy
12/2016 - 04/2009
4Combined Modality Therapy
02/2014 - 05/2011
2Salvage Therapy
01/2022 - 04/2014
2Immunotherapy
09/2019 - 05/2008
1Proton Therapy
01/2022
1Cranial Irradiation
10/2021
1Organ Transplantation
01/2019
1Combination Drug Therapy (Combination Chemotherapy)
01/2018
1Cytoreduction Surgical Procedures
01/2016
1Intravenous Administration
07/2014
1Ligation
07/2014
1Treatment Delay
09/2012
1Transplantation
05/2011